Because what good is a vaccine if people can't actually get it?.
The biotech industry is battling not just antimicrobial resistance but also fears over the spread of superbugs.
With Insitro, Daphne Koller is attempting to create an equal partnership between the life sciences and computer sciences.
The country’s booming industry is seeing a sudden drop in investments, with less liquidity available in the world’s second-largest economy.
Cape Town is running out of water, but professor Sue Harrison might have a solution.
Top space agencies and researchers are turning to biology to create spacecraft that adapt like living creatures to survive future missions.
Startup founder Heather Bowerman plans to launch the first noninvasive test for endometriosis.
Annelise Barron is developing a way to treat Alzheimer’s through the immune system.
A new generation of cell therapies is helping China emerge as an industry leader, challenging American dominance.
Stanford bioengineer Jennifer Cochran is developing proteins that may boost today’s cancer treatments into overdrive.
From the BBC and OZY comes a fresh perspective on the debate about America’s future as a nation and its relation to the world during the 2020 US election.
Gene-editing crops could create high yields of long-lasting, disease-resistant fruits, veggies and grains.
Rachel Haurwitz hopes to change medicine, agriculture and biotechnology as we know them.